AID Logo

Directory >> Laura A. Koutsky, PhD, MSPH

Faculty

Laura A. Koutsky, PhD, MSPH

  • Professor, Department of Epidemiology
  • University of Washington

Dr. Koutsky's research concerns the epidemiology of human papillomavirus (HPV) infections and the prevention of HPV-related neoplasms. Studies to date have demonstrated that genital HPV infections are commonly acquired within a year of first intercourse, a high percentage of infected women develop a cervical, vaginal or vulvar HPV-related squamous intraepithelial lesion, and that prophylactic HPV vaccines are highly effective in preventing vaccine-type infections and lesions. Ongoing projects are designed to (1) define the natural history of HPV infections in men, (2) identify risk factors for oro-pharyngeal HPV infection, (3) assess the frequency and outcome of disclosing positive HPV test results to partners, (4)determine immunologic responses to initial and persisting genital HPV infections, and (5) evaluate the effectiveness and cost-effectiveness of new technologies for cervical cancer prevention. Dr. Koutsky collaborates with Drs. Holmes, Kiviat, Hughes, and Galloway.


Selected Publications


Harris TG, Miller L, Kulasingam SL, Feng Q, Kiviat NB, Schwartz SM, Koutsky LA. Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection. Am J Obstet Gynecol. 2009; 200: 489.e1-8.
PubMed Abstract


Feng Q, Cherne S, Winer RL, Balasubramanian A, Lee SK, Hawes SE, Kiviat NB, Koutsky LA. Development and evaluation of a liquid bead microarray (LBMA) assay for genotyping genital human papillomaviruses. J Clin Microbiol. 2009; 47: 547-43.
PubMed Abstract


Edelstein ZR, Madeleine MM, Hughes JP, Johnson LG, Schwartz SM, Galloway DA, Carter JJ, Koutsky LA. Age of diagnosis of squamous cell cervical carcinoma and early sexual experience. Cancer Epidemiol Biomarkers Prev. 2009; 18: 1070-6.
PubMed Abstract


Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Koutsky LA. Comparison of incident cervical and vulvar/vaginal human papillomavirus infections in newly sexually active young women. J Infect Dis. 2009; 199: 815-8.
PubMed Abstract


Rowhani-Rahbar A, Mao C, Hughes JP, Alvarez FB, Bryan JT, Hawes SE, Weiss NS, Koutsky LA. Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine. Vaccine. 2009; 27(41): 6512-9.
PubMed Abstract

to top